The sale is small relative to market cap and follows a pattern of periodic vesting-related sales by the director. No material signal for the stock. Monitor for any acceleration in selling volume or a change in pattern (e.g., CEO/CFO selling).
ONC drugs
ONC drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 24 $277.12entry
- T+1 · 5mo ago −0.64%α −0.79% · $275.34
- T+5 · 5mo ago +4.91%α +3.21% · $290.74
- T+20 · 4mo ago +15.45%α +13.52% · $319.93
- T+60 · 2mo ago +27.55%α +24.71% · $353.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director John Oyler filed a Form 144 notice of intent to sell 3,410 ADSs (~$933,592 at the filing date) of BeOne Medicines Ltd. (ONC). The shares were acquired via restricted stock vesting under a registered plan. Oyler has sold a total of 10,582 ADSs (~$2.8M) in the prior three months, including three separate sales in June 2026. The filing signals a planned reduction of insider holdings, though the amount is modest relative to the $30.2B market cap.
Key Facts
- Director John Oyler filed Form 144 to sell 3,410 ADSs (~$933,592) on 2026-06-23.
- Shares were acquired via restricted stock vesting under a registered plan.
- Oyler sold 3,693 ADSs (~$980,686) on 2026-06-16, 1,949 ADSs (~$501,355) on 2026-06-11, and 4,940 ADSs (~$1.34M) on 2026-06-08.
- Total sales by Oyler in the prior three months: 10,582 ADSs (~$2.8M).
- Market cap is $30.2B; the proposed sale represents ~0.003% of shares outstanding.
- Recent insider activity (30d): 5 sells totaling $1.5M (Oyler's sales are the majority).
Financial Impact
Proposed sale of ~$934K in ADSs, representing ~0.003% of market cap
Risk Factors
- Insider selling could accelerate if Oyler files additional Form 144s or Form 4s.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006411 |
| Document: 0001950047-26-006411-index.html | 0001950047-26-006411 |
| Document: 0001950047-26-006411.txt | 0001950047-26-006411 |
Track record
27 reports on ONC
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers